Vimarsana
Biggest News Aggregation in the World

Page 9 - Rezolute Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rezolute Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rezolute Inc Today - Breaking & Trending Today

Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million - Vimarsana News

Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million

The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in t...

Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress - Vimarsana News

Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress

15.09.2022 - Announced a $130 million registered direct offering and concurrent private placement priced at-the-market Late-breaking oral presentation from Phase 2b RIZE study of RZ358 presented at ESPE 2022 Phase 2 proof-of-concept study of RZ402 expected to ...

XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events - Vimarsana News

XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events

04.08.2022 - The completion of Regeneron’s acquisition of Checkmate Pharmaceuticals resulted in a $5 million milestone payment to Kuros, $2.5 million of which was paid to XOMA in July. Data from Rezolute and Day One led both companies to announce plans to move ...

Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update - Vimarsana News

Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update

Rezolute, Inc. (NASDAQ:RZLT – Get Rating) was the recipient of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 58,500 shares, a drop of 23.5% from the May 15th total of 76,500 shares. Based on an average trading volume of 212,400 shares, the days-to-cover […]

Virpax Pharmaceuticals (NASDAQ:VRPX) versus Rezolute (NASDAQ:RZLT) Head to Head Review - Vimarsana News

Virpax Pharmaceuticals (NASDAQ:VRPX) versus Rezolute (NASDAQ:RZLT) Head to Head Review

Rezolute (NASDAQ:RZLT – Get Rating) and Virpax Pharmaceuticals (NASDAQ:VRPX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Insider & Institutional Ownership 48.4% of Rezolute shares are owned […]